StartseiteAktuellesBekanntmachungenInnovative Medicines Initiative 2 (IMI2): 7. Aufruf zur Einreichung von Vorschlägen

Innovative Medicines Initiative 2 (IMI2): 7. Aufruf zur Einreichung von Vorschlägen

Stichtag: 17.03.2016 Programmausschreibungen

Die Europäische Kommission hat die siebte Aufforderung zur Einreichung von Vorschlägen für IMI2 veröffentlicht. Die Einreichungsfrist für Kurzanträge der ersten Stufe ist der 17. März 2016.

IMI 2 - Call 7

On 18 December 2015 IMI launched its 7th Call for proposals under IMI 2.

Call topics

  • Validation of translational imaging methods in drug safety assessment (TRISTAN)
  • Identification of druggable targets modulating misfolded proteins in Alzheimer’s and Parkinson’s diseases
  • Pathological neuron-glia interactions in neuropathic pain
  • Dry age-related macular degeneration: development of novel clinical endpoints for clinical trials with a regulatory and patient access intention
  • A comprehensive ‘paediatric preclinical POC platform’ to enable clinical molecule development for children with cancer

Topics under the Big Data for Better Outcomes programme

  • Coordination and support action (CSA) for the big data for better outcomes programme
  • Increase access and use of high quality data to improve clinical outcomes in heart failure (HF), atrial fibrillation (AF), and acute coronary syndrome (ACS) patients

Further information can be found on the Call 7 - Stage 1 page.

Questions?

  • Sign up for the webinars on IMI 2 - Call 7
  • Patients play an important role in IMI's projects and activities. For general advice for patients and other applicants on how best to meaningfully include patients in IMI projects, read our short guide.
  • Contact the IMI Programme Office
  • Download the Call flyer
Quelle: Innovative Medicines Initiative (IMI) Redaktion: Länder / Organisationen: EU Themen: Lebenswissenschaften Förderung

Weitere Informationen

Projektträger